A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft

Kidney International

Volumn 87, Issue 5, 2015, Pages 984-995

  Baron, Daniel ^a,b,c   Ramstein, Gérard ^d   Chesneau, Mélanie ^a,b,c   Echasseriau, Yann ^a,b,c   Pallier, Annaick ^a,b,c   Paul, Chloé ^a,b,c   Degauque, Nicolas ^a,b,c   Hernandez Fuentes, Maria P ^e   Sanchez Fueyo, Alberto ^f   Newell, Kenneth A ^g   Giral, Magali ^a,b,c   Soulillou, Jean Paul ^a,b,c   Houlgatte, Rémi ^h,i   Brouard, Sophie ^a,b,c  

^a Centre National de la Recherche Scientifique   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d INSTITUT DE RECHERCHE EN COMMUNICATIONS ET CYBERNÉTIQUE DE NANTES   (France)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f KING S COLLEGE HOSPITAL   (United Kingdom)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h INSERM   (France)

ⁱ UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

biomarker; gene signature; meta analysis; renal allograft; tolerance; transplantation

Indexed keywords

BIOLOGICAL MARKER; CD14 ANTIGEN; TRANSCRIPTOME;

ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLASSIFICATION; CONTROLLED STUDY; GENE; GENE SIGNATURE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LOW RISK PATIENT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); MONOCYTE; PATIENT MONITORING; PERSONALIZED MEDICINE; PRIORITY JOURNAL; TRANSPLANTATION TOLERANCE; ALLOGRAFT; BLOOD; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; META ANALYSIS; MONONUCLEAR CELL; PHYSIOLOGY; VALIDATION STUDY;

ALLOGRAFTS; BIOMARKERS; HUMANS; IMMUNE TOLERANCE; KIDNEY TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; TRANSCRIPTOME;

EID: 84929132806     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.395     Document Type: Article

References (89)

1. Pascual M, Theruvath T, Kawai T et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590.
2. Dantal J, Hourmant M, Cantarovich D et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351: 623-628.
3. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-2614.
4. Soulillou JP, Giral M. Controlling the incidence of infection and malignancy by modifying immunosuppression. Transplantation 2001; 72: S89-S93.
5. Wimmer CD, Rentsch M, Crispin A et al. The janus face of immunosuppression-de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int 2007; 71: 1271-1278.
6. Lechler RI, Garden OA, Turka LA. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 2003; 3: 147-158.
7. Brouard S, Pallier A, Renaudin K et al. The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant 2012; 12: 3296-3307.
8. Roussey-Kesler G, Giral M, Moreau A et al. Clinical operational tolerance after kidney transplantation. Am J Transplant 2006; 6: 736-746.
9. Orlando G, Hematti P, Stratta RJ et al. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg 2010; 252: 915-928.
10. Braud C, Baeten D, Giral M et al. Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis. J Cell Biochem 2008; 103: 1681-1692.
11. Brouard S, Mansfield E, Braud C et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007; 104: 15448-15453.
12. Lozano JJ, Pallier A, Martinez-Llordella M et al. Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant 2011; 11: 1916-1926.
13. Newell KA, Asare A, Kirk AD et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120: 1836-1847.
14. Sagoo P, Perucha E, Sawitzki B et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010; 120: 1848-1861.
15. Chesneau M, Pallier A, Braza F et al. Unique B cell differentiation profile in tolerant kidney transplant patients. Am J Transplant 2014; 14: 144-155.
16. Louis S, Braudeau C, Giral M et al. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006; 81: 398-407.
17. Pallier A, Hillion S, Danger R et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010; 78: 503-513.
18. Khatri P, Roedder S, Kimura N et al. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med 2013; 210: 2205-2221.
19. Cahan P, Rovegno F, Mooney D et al. Meta-analysis of microarray results: challenges, opportunities, and recommendations for standardization. Gene 2007; 401: 12-18.
20. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511.
21. Chaussabel D, Quinn C, Shen J et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 2008; 29: 150-164.
22. Fulcher JA, Hashimi ST, Levroney EL et al. Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix. J Immunol 2006; 177: 216-226.
23. Haddad R, Guardiola P, Izac B et al. Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood. Blood 2004; 104: 3918-3926.
24. Hoffmann R, Seidl T, Neeb M et al. Changes in gene expression profiles in developing B cells of murine bone marrow. Genome Res 2002; 12: 98-111.
25. Jourdan M, Caraux A, De VJ et al. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. Blood 2009; 114: 5173-5181.
26. Lee MS, Hanspers K, Barker CS et al. Gene expression profiles during human CD4+ T cell differentiation. Int Immunol 2004; 16: 1109-1124.
27. Luckey CJ, Bhattacharya D, Goldrath AW et al. Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc Natl Acad Sci USA 2006; 103: 3304-3309.
28. Subramanian A, Tamayo P, Mootha VK et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
29. Beer DG, Kardia SL, Huang CC et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8: 816-824.
30. Bhattacharjee A, Richards WG, Staunton J et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001; 98: 13790-13795.
31. Fan C, Oh DS, Wessels L et al. Concordance among gene-expressionbased predictors for breast cancer. N Engl J Med 2006; 355: 560-569.
32. Lossos IS, Czerwinski DK, Alizadeh AA et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 2004; 350: 1828-1837.
33. Miklos GL, Maleszka R. Microarray reality checks in the context of a complex disease. Nat Biotechnol 2004; 22: 615-621.
34. Ioannidis JP. Microarrays and molecular research: noise discovery? Lancet 2005; 365: 454-455.
35. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005; 365: 488-492.
36. Moreau Y, Aerts S, Moor BD et al. Comparison and meta-analysis of microarray data: from the bench to the computer desk. Trends Genet 2003; 19: 570-577.
37. Campain A, Yang YH. Comparison study of microarray meta-analysis methods. BMC Bioinformatics 2010; 11: 408.
38. Hong F, Breitling R. A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments. Bioinformatics 2008; 24: 374-382.
39. Choi JK, Yu U, Kim S et al. Combining multiple microarray studies and modeling interstudy variation. Bioinformatics 2003; 19: i84-i90.
40. Cobb JP, Mindrinos MN, Miller-Graziano C et al. Application of genomewide expression analysis to human health and disease. Proc Natl Acad Sci USA 2005; 102: 4801-4806.
41. Eady JJ, Wortley GM, Wormstone YM et al. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics 2005; 22: 402-411.
42. Whitney AR, Diehn M, Popper SJ et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 2003; 100: 1896-1901.
43. Radich JP, Mao M, Stepaniants S et al. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics 2004; 83: 980-988.
44. Ein-Dor L, Zuk O, Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 2006; 103: 5923-5928.
45. Irizarry RA, Warren D, Spencer F et al. Multiple-laboratory comparison of microarray platforms. Nat Methods 2005; 2: 345-350.
46. Leek JT, Scharpf RB, Bravo HC et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet 2010; 11: 733-739.
47. Yauk CL, Berndt ML, Williams A et al. Comprehensive comparison of six microarray technologies. Nucleic Acids Res 2004; 32: e124.
48. Ramaswamy S, Ross KN, Lander ES et al. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33: 49-54.
49. Rhodes DR, Barrette TR, Rubin MA et al. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res 2002; 62: 4427-4433.
50. Dudley JT, Tibshirani R, Deshpande T et al. Disease signatures are robust across tissues and experiments. Mol Syst Biol 2009; 5: 307.
51. Flechner SM, Kurian SM, Head SR et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004; 4: 1475-1489.
52. Horwitz PA, Tsai EJ, Putt ME et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 2004; 110: 3815-3821.
53. Vasconcellos LM, Schachter AD, Zheng XX et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998; 66: 562-566.
54. Villeda SA, Plambeck KE, Middeldorp J et al. Young blood reverses agerelated impairments in cognitive function and synaptic plasticity in mice. Nat Med 2014; 20: 659-663.
55. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000; 106: 145-155.
56. Danger R, Pallier A, Giral M et al. Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. J Am Soc Nephrol 2012; 23: 597-606.
57. Fujino M, Kitazawa Y, Kawasaki M et al. Differences in lymphocyte gene expression between tolerant and syngeneic liver grafted rats. Liver Transplant 2004; 10: 379-391.
58. Kirk AD, Turgeon NA, Iwakoshi NN. B cells and transplantation tolerance. Nat Rev Nephrol 2010; 6: 584-593.
59. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood 2008; 112: 1570-1580.
60. Chen X, Jensen PE. Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells. J Immunol 2007; 179: 2046-2050.
61. Deng S, Moore DJ, Huang X et al. Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol 2007; 178: 6028-6032.
62. Fillatreau S, Sweenie CH, McGeachy MJ et al. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3: 944-950.
63. Heyzer-Williams LJ, Heyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol 2005; 23: 487-513.
64. Moulin V, Andris F, Thielemans K et al. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med 2000; 192: 475-482.
65. Clatworthy MR, Watson CJ, Plotnek G et al. B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med 2009; 360: 2683-2685.
66. Silva HM, Takenaka MC, Moraes-Vieira PM et al. Preserving the B-cell compartment favors operational tolerance in human renal transplantation. Mol Med 2012; 18: 733-743.
67. Coelho V, Saitovitch D, Kalil J et al. Rethinking the multiple roles of B cells in organ transplantation. Curr Opin Organ Transplant 2013; 18: 13-21.
68. Haynes LD, Jankowska-Gan E, Sheka A et al. Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients. Am J Transplant 2012; 12: 640-648.
69. Moraes-Vieira PM, Takenaka MC, Silva HM et al. GATA3 and a dominant regulatory gene expression profile discriminate operational tolerance in human transplantation. Clin Immunol 2012; 142: 117-126.
70. Brouard S, Le BA, Dufay A et al. Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients. Transplant Int 2011; 24: 536-547.
71. Zoller KM, Cho SI, Cohen JJ et al. Cessation of immunosuppressive therapy after successful transplantation: a national survey. Kidney Int 1980; 18: 110-114.
72. Deng MC, Eisen HJ, Mehra MR et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006; 6: 150-160.
73. Wang J, Do KA, Wen S et al. Merging microarray data, robust feature selection, and predicting prognosis in prostate cancer. Cancer Inform 2006; 2: 87-97.
74. Baron D, Montfort J, Houlgatte R et al. Androgen-induced masculinization in rainbow trout results in a marked dysregulation of early gonadal gene expression profiles. BMC Genomics 2007; 8: 357.
75. Baron D, Magot A, Ramstein G et al. Immune response and mitochondrial metabolism are commonly deregulated in DMD and aging skeletal muscle. PLoS ONE 2011; 6: e26952.
76. Baron D, Dubois E, Bihouee A et al. Meta-analysis of muscle transcriptome data using the MADMuscle database reveals biologically relevant gene patterns. BMC Genomics 2011; 12: 113.
77. Lamirault G, Meur NL, Roussel JC et al. Molecular risk stratification in advanced heart failure patients. J Cell Mol Med 2010; 14: 1443-1452.
78. Quille ML, Carat S, Quemener-Redon S et al. High-throughput analysis of promoter occupancy reveals new targets for Arx, a gene mutated in mental retardation and interneuronopathies. PLoS ONE 2011; 6: e25181.
79. Baron D, Bihouee A, Teusan R et al. MADGene: retrieval and processing of gene identifier lists for the analysis of heterogeneous microarray datasets. Bioinformatics 2011; 27: 725-726.
80. Eisen MB, Spellman PT, Brown PO et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868.
81. Tavazoie S, Hughes JD, Campbell MJ et al. Systematic determination of genetic network architecture. Nat Genet 1999; 22: 281-285.
82. Zeeberg BR, Feng W, Wang G et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003; 4: R28.
83. Alizadeh AA, Ross DT, Perou CM et al. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 2001; 195: 41-52.
84. Boorsma A, Foat BC, Vis D et al. T-profiler: scoring the activity of predefined groups of genes using gene expression data. Nucleic Acids Res 2005; 33: W592-W595.
85. Feuerstein P, Puard V, Chevalier C et al. Genomic assessment of human cumulus cell marker genes as predictors of oocyte developmental competence: impact of various experimental factors. PLoS ONE 2012; 7: e40449.
86. Lee HK, Hsu AK, Sajdak J et al. Coexpression analysis of human genes across many microarray data sets. Genome Res 2004; 14: 1085-1094.
87. Feng C, Araki M, Kunimoto R et al. GEM-TREND: a web tool for gene expression data mining toward relevant network discovery. BMC Genomics 2009; 10: 411.
88. Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537.
89. Simon R, Radmacher MD, Dobbin K et al. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003; 95: 14-18.